Source: New England Journal of Medicine In November 2022, the FDA granted fast-track approval to tirzepatide for the treatment of adult obesity after approving it earlier in the year for the treatment of type II diabetes
Patient-level weight change data were unavailable, so the analysis cannot explain whether the observed differences were driven by weight loss, metabolic control, cardiovascular effects, direct tumor biology, or differences in patient selection
Look for powders that contain a complete amino acid profile
By supporting acetylcholine levels, it strengthens neuromuscular junctions, which can reduce feelings of weakness and improve mental clarity
Bowen RS, Moodley J, Dutton MF, et al
Topfs outstanding Tweetorial on Hyponatremia (3) CritCases 10 Hyponatremia Associated Seizures